Tag: Novavax

Published by: Montreal Gazette
Published on: March 11, 2025
By Jacob Serebrin

The federal government has cancelled a deal with vaccine maker Novavax to manufacture COVID-19 vaccine in Montreal, the company said in a filing with the U.S. securities regulator.

Novavax told the Securities and Exchange Commission that the Canadian government cancelled the deal March 7 after the company failed to meet a Dec. 31, 2024 deadline to get regulatory approval for a COVID-19 vaccine using ingredients made at the federally-owned Biologics Manufacturing Centre in Montreal.

Comments closed

Novavax

You’ve never heard of the Covid booster with the fewest side effects

Published December 18, 2024

Published by: Vox
Published on: December 18, 2024
By Keren Landman, MD

The first time I got a Novavax Covid vaccine, it felt almost subversive.

Over the previous few years, every mRNA-based booster I’d gotten — the ones made by Moderna and Pfizer — had felt like a two-day bout of the flu. I’d gamely booked sick days into my calendar and sucked it up through fevers, headaches, and exhaustion, comforting myself with ibuprofen and the knowledge that at least I was keeping my elderly parents safe.

Two and a half years into the pandemic, the Food and Drug Administration approved a Covid vaccine made by biotech company Novavax using older vaccine production technology. Licensed for people 12 and over, it was nearly as effective at Covid prevention as Pfizer and Moderna’s mRNA vaccines — and, as I noted with great interest, it had fewer side effects. In 2023, I got one.

Comments closed

vaccines

Let’s put Montreal’s idle pharmaceutical plant to good use

Published November 28, 2024

Published by: Montreal Gazette
Published on: November 28, 2024
By Adam R. Houston, Jason Nickerson

When COVID-19 first struck, Canada had a problem: It lacked domestic capacity to manufacture vaccines. Today, the government of Canada faces the opposite problem: It owns a factory that isn’t manufacturing vaccines.

The Biologics Manufacturing Centre (BMC) in Montreal was completed in 2021 at the cost of $126 million, and fully licensed by Health Canada in 2022. However, a 2021 deal with Novavax to produce their COVID-19 vaccine looks increasingly unlikely to produce a single dose. Indeed, despite annual operating costs around $17 million a year, the BMC has never produced anything.

Comments closed

vaccines

Three years and waiting for Canada’s made-in-Montreal COVID shot

Published November 4, 2024

Published by: Montreal Gazette
Published on: November 4, 2024
By Jacob Serebrin

Vaccine production is nearly three years behind schedule at a federally owned plant in Montreal and the future of a deal between Ottawa and an American company to make COVID-19 vaccines here is now under review.

Comments closed

vaccines

Vaccine manufacturer won’t be making COVID shots at Montreal plant this winter

Published October 6, 2024

Published by: The Globe and Mail
Published on: October 6, 2024
By Kelly Grant

At the height of the pandemic in February of 2021, Prime Minister Justin Trudeau announced he had found a partner to make millions of doses…

Comments closed

vaccines

COVID-19 boosters start rolling out to some Canadians. Who can get them?

Published October 4, 2024

Published by: Global News
Published on: October 4, 2024
By Saba Aziz

Updated COVID-19 vaccines are starting to roll out to some high-risk Canadians, but others will have to wait a little while longer before these new shots are offered to them.

Last month, Health Canada approved Pfizer and Moderna’s latest COVID-19 vaccines targeting the most recent variants of the virus.

Both shots are approved for everyone aged six months and older.

The new mRNA vaccines from both pharmaceutical companies target the KP.2 subvariant of Omicron that was dominating COVID-19 spread earlier this year.

Comments closed

vaccines

For Canadians seeking a non-mRNA COVID vaccine, lack of Novavax shot is ‘unfair,’ advocates say

Published October 3, 2024

Published by: CTV News / The Canadian Press
Published on: October 3, 2024
By Hannah Alberga, Nicole Ireland

The federal government’s decision to not provide Novavax’s COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say, as some Canadians look to the U.S. to get the shot.

The Public Health Agency of Canada said it won’t provide the protein-based vaccine called Nuvaxovid because the manufacturer required a minimum order that far exceeds last year’s uptake of the vaccine.

The health agency said 125,000 Nuvaxovid doses were ordered in 2023, but only 5,529 were administered. This fall, it will only supply provinces and territories with the reformulated Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines.

But some Canadians who say they are immunocompromised and have had adverse reactions to the mRNA vaccines are calling the decision unfair.

Comments closed

vaccines

Canadian government not ordering Novavax’s protein-based COVID-19 vaccine this year

Published October 1, 2024

Published by: The Canadian Press
Published on: October 1, 2024
By Nicole Ireland

TORONTO – The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing low demand.

It says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.

The agency says a very small portion of the doses ordered in 2023 were used and that its decision reflects efforts to limit vaccine wastage.

It is distributing two mRNA vaccines — made by Pfizer-BioNTech and Moderna — that are approved for adults and children six months and older.

Comments closed

vaccines

Health Canada approves Pfizer-BioNTech’s updated COVID-19 vaccine

Published September 24, 2024

Published by: The Canadian Press
Published on: September 24, 2024
By Nicole Ireland, Hannah Alberga

Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.

Pfizer-BioNTech’s mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version that targeted the XBB.1.5 Omicron subvariant.

The approval of Comirnaty follows last week’s authorization of Moderna’s updated Spikevax mRNA vaccine and Novavax’s updated protein-based vaccine, Nuvaxovid.

Comments closed

Alberta

Moderna’s updated COVID-19 vaccine is coming to Alberta, but Novavax shots are not

Published September 23, 2024

Published by: CBC News
Published on: September 23, 2024
By Jennifer Lee

With the approval of Moderna’s updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans will opt to roll up their sleeves to get one.

Last week, Health Canada announced it had authorized Moderna’s new formulation, which targets the recent KP.2 subvariant, and that shipments would arrive within days.

A decision on Pfizer’s new formulation is expected in the next few weeks.

Comments closed

vaccines

No good option: These Canadians want to be protected against COVID but are unhappy with the choice of vaccines this fall

Published September 13, 2024

Published by: Investigative Journalism Foundation
Published on: September 13, 2024
By Tori Marlan

The federal government has decided against procuring a protein-based COVID-19 vaccine for the fall immunization campaign — despite it being the only type that some immunocompromised people say they have been able to tolerate.

While the mRNA vaccines made by Pfizer and Moderna are effective at preventing severe illness, hospitalization and death, some people with autoimmune diseases say the jabs can come with a terrible trade-off.

Comments closed

vaccines

No Novavax COVID-19 vaccine in Canada this fall, immunocompromised N.B. woman feels ‘expendable’

Published September 6, 2024

Published by: CBC News
Published on: September 6, 2024
By Bobbi-Jean MacKinnon

Linda Wilhelm, 64, of Bloomfield, N.B., is planning a road trip to the United States. But it’s not to go sightseeing or shopping.

Wilhelm, who suffers from severe rheumatoid arthritis, hopes to get the updated Novavax COVID-19 vaccine, which won’t be available in Canada as part of the fall vaccination campaign, unless provinces and territories order doses on their own.

Wilhelm, president of the Canadian Arthritis Patient Alliance and a member of the Canadian Immunocompromised Advocacy Network, says the protein-based vaccine is a better option for immunocompromised people like her than the more common Pfizer-BioNTech and Moderna mRNA vaccines. She says she feels “expendable” and urges the federal government to reconsider.

Less than two months ago, the network wrote to numerous federal, provincial and territorial officials, calling for improved access to Novavax and increased awareness.

Comments closed

Novavax now! We need access to the Novavax COVID-19 vaccine!

Photo of two vials of a vaccine and a syringe, accompanied by white and gold text on a blue background reading: Novavax now! We need access to the Novavax COVID-19 vaccine. StillCoviding.ca #NovavaxNow Photo: oasisamuel / Adobe.

take action

Novavax now! We need access to the Novavax COVID-19 vaccine!

Published August 25, 2024

📣 Let PHAC and health ministers know you want timely access to the Novavax COVID-19 vaccine this fall

✉️ Send letters to PHAC and health ministers to voice your support for access to the Novavax COVID-19 vaccine this fall. Use our online tool to send emails.

Comments closed

vaccines

FDA may greenlight updated Covid-19 vaccines as soon as next week, sources say

Published August 16, 2024

Published by: CNN
Published on: August 16, 2024
By Meg Tirrell

The US Food and Drug Administration is poised to sign off as soon as next week on updated Covid-19 vaccines targeting more recently circulating strains of the virus, according to two sources familiar with the matter, as the country experiences its largest summer wave in two years.

The agency is expected to greenlight updated mRNA vaccines from Moderna and Pfizer/BioNTech that target a strain of the virus called KP.2, said the sources, who declined to be named because the timing information isn’t public. It was unclear whether the agency simultaneously would authorize Novavax’s updated shot, which targets the JN.1 strain.

The move would be several weeks ahead of last year’s version of the vaccine, which got FDA signoff on September 11.

Comments closed

Novavax

Analysis finds positive risk-benefit for Novavax COVID vaccine

Published March 18, 2024

Published by: CIDRAP
Published on: March 18, 2024
By Lisa Schnirring

An analysis of the Novavax COVID-19 vaccine using clinical and real-world data found that the benefits outweighed the risk of myocarditis or pericarditis, a team…

Comments closed

vaccines

Older, immunocompromised people may get COVID-19 vaccine dose in spring, NACI says

Published January 12, 2024

Published by: CTV News / The Canadian Press
Published on: January 12, 2024

Canada’s National Advisory Committee on Immunization says some groups of people vulnerable to severe illness from COVID-19 should be eligible for another dose of vaccine in the spring.

The recommendation issued Friday says people aged 65 and older, residents of long-term care homes and seniors living in other congregate settings may get another shot of the vaccine targeted to the XBB.1.5 variant.

It also says children and adults aged six months and older who are moderately to severely immunocompromised due to an underlying condition may also get the booster.

Comments closed

Alberta

Albertans can now book appointments for the updated Novavax vaccine

Published January 3, 2024

Published by: CBC News
Published on: January 3, 2024
By Jennifer Lee

A limited supply of the updated Novavax vaccine is rolling out in Alberta this week with appointment booking starting Wednesday and shots going into arms as of Friday.

Alberta Health said it has approximately 5,000 doses of the Novavax XBB.1.5 vaccine in stock.

The latest version of the protein-based vaccine was approved by Health Canada in early December.

Comments closed

vaccines

Just 15% of Canadians got updated COVID vaccines this fall, new figures show

Published December 20, 2023

Published by: CBC News
Published on: December 20, 2023
By Lauren Pelley

Canadians raced to get vaccinated against COVID-19 in the first years of the pandemic, but data suggests there’s far less of a rush to get the latest shots available this fall.

Federal figures show only 15 per cent of the population aged five and up had received an updated vaccine by Dec. 3. And while older age groups had higher uptake rates, more than half of higher-risk older adults still hadn’t gotten a dose by early December, either.

Comments closed

Tag: Novavax

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

📣 Let PHAC and health ministers know you want timely access to the Novavax COVID-19 vaccine this fall

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts